Search Results 11-20 of 8336 for b52.gold

  1. Medical Research & Education - Mayo Clinic News Network

    Cancer. ALTTO Test of Dual HER2 Blockade Finds Single Agent – Trastuzumab – Remains Gold Standard. Paul Scotti. June 1, 2014. Cancer. Tumor Size is Defining ...

  2. https://www.mayoclinic.org/spanish_organization_concepts.xml

  3. A Study of FT 2102 in Participants with Advanced Solid Tumors and Gliomas with an IDH1 Mutation - Mayo Clinic

    About this study. The purpose of this is to evaluate the safety, effectivess, pharmacokinetics, and pharmacodynamics of FT-2102 as a single agent and in ...

  4. https://www.mayoclinic.org/chinese_patient_consumer_web.xml

  5. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  6. Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. - Mayo Clinic

    About this study. This open label, randomised, controlled, multi-centre phase III study will assess the efficacy and safety of single agent olaparib vs ...

  7. Carcinoma Clinical Trials - Mayo Clinic Research

    The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...

  8. https://www.mayoclinic.org/chinese_organization_concepts.xml

  9. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...

  10. https://www.mayoclinic.org/chinese_patient_consumer_video.xml